Admission Date:  [**2195-11-2**]              Discharge Date:   [**2195-11-6**]  Date of Birth:  [**2131-9-26**]             Sex:   M  Service: NEUROSURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1271**] Chief Complaint: Headache  Major Surgical or Invasive Procedure: NONE  History of Present Illness: 64M s/p ground level fall with left convexity skim SDH, traumatic SAH, Lt frontal contusion.
Prior to hospitalization pt on coumadin for Afib  Past Medical History: Mitral valve repair Syncope afib HTN hyperlipidemia benign prostatic hypertrophy  Social History: Family supportive Lives at home with wife.
No substernal sensation Abd: Soft, NT, BS+,no nausea or vomiting today Extrem: Warm and well-perfused.
No peripheral edema Neuro:CN II-XII.
C/O Headache frontal/forehead [**5-30**].
Relieved with pain meds.
Pertinent Results: [**2195-11-5**] 06:20AM BLOOD WBC-9.7 RBC-3.84* Hgb-12.5* Hct-35.8* MCV-93 MCH-32.5* MCHC-34.8 RDW-13.4 Plt Ct-174 [**2195-11-4**] 04:00PM BLOOD WBC-9.7 RBC-3.81* Hgb-12.7* Hct-35.6* MCV-94 MCH-33.3* MCHC-35.6* RDW-13.4 Plt Ct-139* [**2195-11-5**] 06:20AM BLOOD Plt Ct-174  Brief Hospital Course: Admitted to ICU for close neurologic monitoring which included endotracheal intubate for airway protection.
Since that date he has progressed well without neurosurgical intervention.
Cardiology was consulted as well for any possible cardiac syncope.
Hydromorphone 2 mg Tablet Sig: One (1) Tablet PO every four (4) hours as needed for headache: hold for excessive sleepiness.
You should avoid any straining such as with moving bowels, coughing or bending.
You should also notify the doctor if you develop nausea, vomiting or any vision changes.
It is not uncommon to have prolonged headaches.
GIVEN YOUR HISTORY OF FALLS, YOU ARE AT HIGH RISK FOR REBLEEDING SHOULD YOU GO BACK ON COUMADIN, BUT FROM A NEUROSURGICAL PERSPECTIVE AND PER DR. [**Last Name (STitle) **] IT WOULD BE SAFE TO RESUME YOUR COUMADIN IN ONE MONTH SHOULD YOUR CARDIOLOGIST FEEL THAT YOU SHOULD REMAIN ON THE MEDICATION.
